Lockton is the world’s largest independent insurance brokerage providing customized solutions to meet your organization's risk, benefits and retirement needs.
Latest News & Insights
GLP-1s without Lifestyle Modification is a Recipe for Failure for Obesity Treatment
With various studies predicting the global market for GLP-1s exceeding a staggering $471 billion by 2032, employers should be asking: What is my strategy for achieving an ROI for the spend on these expensive weight loss medications? In the U.S. alone …
Cancer is a Long Game: What’s Your Strategy?
“What can we do about cancer?” This is a question asked by almost every employer our clinical team has met with this year. Cancer is a well-known cost driver in health plans. Lockton’s internal data confirms that: Cancer is the number-two diagnosis …
Weight Loss Medications Without a Holistic Approach Invites Discontinuation and Lost Inves …
Early discontinuation of medications happens for various reasons – and for the increasingly popular GLP-1 medications, they include supply chain issues, cost and intolerable side effects ranging from nausea and diarrhea to more severe complications l …
2024 Lockton National Benefits Survey
The 2024 Lockton Survey includes responses from more than 1,600 employers from a variety of industries and group sizes, with different philosophies and priorities as they look to offer competitive benefit programs while managing growing costs.